So-Young International Inc
NASDAQ:SY

Watchlist Manager
So-Young International Inc Logo
So-Young International Inc
NASDAQ:SY
Watchlist
Price: 2.82 USD -0.7% Market Closed
Market Cap: $288.4m

So-Young International Inc
Investor Relations

So-Young International, Inc. engages in discovering, evaluating and reserving medical aesthetic services. The company is headquartered in Beijing, Beijing. The company went IPO on 2019-05-02. The firm operates through two segments: Information Services segment and Reservation Services segment.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 17, 2025
AI Summary
Q3 2025

Revenue Beat: Total Q3 revenue was RMB 386.7 million, up 4% year-over-year and about 8% above the high end of guidance.

Core Business Growth: Branded aesthetic center revenue surged 305% year-over-year to RMB 184 million, further strengthening its role as the company's growth engine.

Profitability: Net loss attributable to So-Young was RMB 64.3 million, a swing from net income of RMB 20.3 million last year; management attributed this to a revenue drop in non-core businesses.

Guidance Raised: Q4 treatment services revenue is expected to reach RMB 216–226 million, representing 166–178% growth year-over-year.

Clinic Expansion: The company now operates 42 centers and aims to reach 50 by year-end, with plans for at least 35 new centers in 2026.

Membership & Retention: Core members rose 40% quarter-over-quarter, accounting for a high share of revenue and nearly 70% repurchase rate.

Product Innovation: The launch of Miracle PLLA version 3 generated strong demand, with the first 5,000 units selling out quickly.

Key Financials
Revenue
RMB 386.7 million
Aesthetic Treatment Services Revenue
RMB 183.6 million
Information and Reservation Services Revenue
RMB 117.2 million
Sales of Medical Products and Maintenance Services Revenue
RMB 67 million
Other Services Revenue
RMB 18.9 million
Cost of Revenues
RMB 203.8 million
Cost of Aesthetic Treatment Services
RMB 140.1 million
Cost of Information and Reservation Services
RMB 12.9 million
Cost of Medical Products Sold and Maintenance Services
RMB 35.6 million
Cost of Other Services
RMB 15.2 million
Total Operating Expenses
RMB 255.6 million
Sales and Marketing Expenses
RMB 130.7 million
General and Administrative Expenses
RMB 88.6 million
R&D Expenses
RMB 36.3 million
Income Tax Expenses
RMB 1.1 million
Net Loss Attributable to So-Young International Inc.
RMB 64.3 million
Net Income Attributable to So-Young International Inc. (Prior Year)
RMB 20.3 million
Basic and Diluted Losses per ADS
RMB 0.64
Cash and Cash Equivalents, Restricted Cash, Term Deposits and Short-term Investments
RMB 942.8 million
Treatment Services Revenue Guidance for Q4 2025
RMB 216–226 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Xing Jin
Co-Founder, CEO & Chairman
No Bio Available
Mr. Tao Yu
Co-Founder & Consultant
No Bio Available
Mr. Hui Zhao
CFO & Director
No Bio Available
Mr. Nan Huang
Chief HR Officer
No Bio Available
Mr. Xiaodong Ying
Chief Growth Officer & Director
No Bio Available
Ms. Vivian XU
Investor Relations Officer
No Bio Available
Ms. Mona Qiao
Investor Relation Officer
No Bio Available

Contacts

Address
BEIJING
Beijing
3/F, Wangjing Soho-Tower 3A, Chaoyang District
Contacts
+861057076564.0
www.soyoung.com